Pharmacoepidemiology and Drug Safety

Papers
(The H4-Index of Pharmacoepidemiology and Drug Safety is 20. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-06-01 to 2025-06-01.)
ArticleCitations
Issue Information72
Issue Information48
47
Exposure to Valsartan Products Containing Nitrosamine Impurities in the United States, Canada, and Denmark40
Correction to “Effect of tramadol and DOACs with special attention to dabigatran on concomitant use, on the risk of mayor bleeding using BIFAP database in Spain”37
Data Resource Profile: The Danish National Hospital Medicine Register32
Management of epilepsy in Lebanon: Medication reviews and drug‐related problems31
Antibiotics and Drug Reaction With Eosinophilia and Systemic Symptoms (DRESS) Syndrome: Analysis of Brazilian Pharmacovigilance Registries30
Mixed Impact of Direct Healthcare Professional Communications When Considering Proximal Outcomes and the Targeted Population: A Systematic Review28
Validation of Chronic Inflammatory Demyelinating Polyradiculoneuropathy Coding in US Claims Data27
Validation of diagnosis codes for chorioamnionitis in medical encounter data, 2013–201827
Hepatitis B vaccine and risk of acute myocardial infarction among individuals with diabetes mellitus26
External validity in distributed data networks26
Optimizing therapeutic decision‐making for off‐label medicines use: A scoping review and consensus recommendations for improving practice and research+24
Quantitative Benefit–Risk Assessment of Vaccination Against COVID‐19: A Systematic Review23
Letter to the Editor23
Comparison of drug prescribing before and during the COVID‐19 pandemic: A cross‐national European study23
Predicting obesity and smoking using medication data: A machine‐learning approach22
International trends in prescription opioid sales among developed and developing economies, and the impact of the COVID‐19 pandemic: A cross‐sectional analysis of 66 countries22
Issue Information22
0.53030204772949